Overview
With over $550 million in assets under management, H.I.G. BioHealth Partners invests in a broad range of healthcare companies across multiple sectors and stages of development. Our seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. We invest in companies developing novel products for significant unmet medical needs more >
Portfolio
Recent News
- Wed, Mar 8th, 2023 — Augmedics Launches New Features, New Indications in Expansion of xvision Augmented Reality…
- Tue, Jan 24th, 2023 — Joseph C. Cosgrove Appointed as President and Chief Executive Officer of Leiters
- Mon, Jan 23rd, 2023 — Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
- Tue, Nov 22nd, 2022 — BIOVECTRA Named One of Canada’s Top Employers Again in 2023
- Tue, Oct 4th, 2022 — Endpoint Health Unveils Precision Immunology Program to Address Tissue Factor-Mediated Inflammation…
- Thu, Sep 15th, 2022 — Zerigo Health Announces Release of Eczema Solution
- Thu, Sep 15th, 2022 — Evernorth Expands Its Digital Health Formulary To Help Patients Better Manage Sleep Issues,…
- Thu, Sep 8th, 2022 — Artemis Health and Zerigo Health Announce Partnership to Help Employers and Health Plans Better…
- Wed, Jun 29th, 2022 — Leiters Joins the End Drug Shortages Alliance
- Thu, Jun 9th, 2022 — Memorial Hermann Health System Joins Existing Investors in Leiters, a 503B Outsourced Pharmaceutical…